Skip to main content
Marc Greenblatt, MD, Oncology, Burlington, VT

MarcStevenGreenblattMD

Oncology Burlington, VT

Associate Professor, Medicine, University of Vermont College of Medicine

Are you Dr. Greenblatt?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 48 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    111 Colchester Ave

    Burlington, VT 05401
    Phone+1 802-847-8400

Summary

  • Dr. Marc Greenblatt, MD is an oncologist in Burlington, Vermont. He is currently licensed to practice medicine in Vermont, New York, and New Mexico. He is affiliated with University of Vermont Medical Center and is an Associate Professor at University of Vermont College of Medicine.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineResidency, Internal Medicine, 1983 - 1987
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2019 - 2026
  • VT State Medical License
    VT State Medical License 1995 - 2026
  • NM State Medical License
    NM State Medical License 1984 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Risk-Reducing Hysterectomy and Bilateral Salpingo-Oophorectomy in Female Heterozygotes of Pathogenic Mismatch Repair Variants: A Prospective Lynch Syndrome Database Report
    Risk-Reducing Hysterectomy and Bilateral Salpingo-Oophorectomy in Female Heterozygotes of Pathogenic Mismatch Repair Variants: A Prospective Lynch Syndrome Database ReportDecember 1st, 2020
  • Study Provides Clearer Picture of Cancer Risk
    Study Provides Clearer Picture of Cancer RiskJanuary 27th, 2014

Grant Support

  • Computational &Laboratory Study Of P16/Ink4 MutationsNational Cancer Institute2002–2004
  • Computational &Laboratory Study Of P16/Ink4 MutationsNational Cancer Institute2002
  • Mutations In The HPRT Gene, Smoking And Lung CancerNational Center For Research Resources1997–2000